Clinical trial
Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose…
NCT00431379 · Wake Forest University Health Sciences, Other · Withdrawn
Key facts
| NCT number | NCT00431379 |
|---|---|
| Title | Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study |
| Official title | Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study: Phase I |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Acute Respiratory Distress Syndrome |
| Intervention type | Drug |
| Interventions | Tenecteplase |
| Enrollment | 0 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 5, 2007 |
| Last update posted | Oct 16, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: